Anti-angiogenesis effects of meisoindigo on chronic myelogenous leukemia in vitro

Leukemia Research

Volumn 30, Issue 1, 2006, Pages 54-59

  Xiao, Zhijian ^a   Wang, Yi ^a   Lu, Lin ^a   Li, Zongjin ^a   Peng, Zhi ^a   Han, Zhongchao ^a   Hao, Yushu ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

Adherence; Apoptosis; Chronic myelogenous leukemia; Differentiation; Endothelial cells; Meisoindigo; Vascular endothelial growth factor (VEGF)

Indexed keywords

ANTILEUKEMIC AGENT; CHINESE DRUG; LIPOCORTIN 5; MATRIGEL; MEISOINDIGO; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BONE MARROW; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CHINESE MEDICINE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN SECRETION; TIME SERIES ANALYSIS; VASCULAR ENDOTHELIUM;

ANGIOGENESIS INHIBITORS; APOPTOSIS; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FEMALE; HUMANS; INDOLES; K562 CELLS; LEUKEMIA, MYELOID, CHRONIC; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 27844447144     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.05.012     Document Type: Article

References (27)

1. Z. Xiao, L. Qian, B. Liu, and Y. Hao Meisoindigo for the freatment of chronic myelogenous leukaemia Br J Haematol 111 2000 711 712
2. Z. Xiao, Y. Hao, B. Liu, and L. Qian Indirubin and meisoindigo in the treatment of chronic myelogenous leukemia in China Leuk Lymphoma 43 2002 1763 1768
3. B.C. Liu, L.S. Qian, Y. Wang, Z. Xiao, J.L. Han, and X. Li The clinical effect and mechanism of meisoindigo in chronic granulocytic leukaemia Chin J Prac Intern Med 20 2000 610 612
4. Cooperative Group of Phase III Clinical Trial on Meisoindigo. Phase III clinical trial on meisoindigo in the treatment of chronic myelogenous leukemia. Chin J Hematol 1997;18:69-72.
5. J. Folkman Clinical application of research on angiogenesis N Engl J Med 333 1995 1757 1763
6. A.R. Perez-Atayde, S.E. Sallan, U. Tedrow, S Connors, E. Allred, and J. Folkman Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblasttic leukaemia Am J Pathol 150 1997 815 821
7. L.G. Lundberg, R. Lerner, P. Sundelin, R. Rogers, J. Folkman, and J. Palmblad Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity Am J Pathol 157 2000 15 19
8. A. Aguayo, H. Kantarjian, T. Manshouri, C. Gidel, E. Estey, and D. Thomas Agiogenesis in acute and chronic leukemias and myelodysphlastic syndromes Blood 96 2000 2240 2245
9. M.Z. Ratajczak, J. Ratajczak, B. Machalinski, M. Majka, W. Marlicz, and A. Carter Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PLGF) in regulating human haemopietic cell growth Br J Haematol 103 1998 969 979
10. L. Legros, C. Bourcier, A. Jacquel, F. Mahon, J. Cassuto, and P. Auberger Imatinib mesylate (STI571) decreases the vascular endothelial growth factor plasma concentration in patients with chronic myeloid leukaemia Blood 104 2004 495 501
11. W.T. Bellamy, L. Richter, Y. Rrutiger, and T.M. Grogan Expression of vascular endothelial growth factor and its receptors in hematolpoietic malignancies Cancer Res 59 1999 728 733
12. F. Bertolini, P. Mancuso, A. Gobbi, and G. Pruneri The thin red line: angiogenesis in normal and malignant hematopoiesis Exp Hematol 28 2000 993 1000
13. H.M. Kvasnicka, J. Thiele, P. Staib, A. Schmitt-Graeff, M. Griesshammer, and J. Klose Reversal of bone marrow angiogenesis in chronic myeloid leukemia following imatinib mesylate (STI 571) therapy Blood 103 2004 3549 3551
14. A.F. List Vascular endothelial growth factor signaling pathway as an emerging target in hematologic malignancies Oncologist 6 Suppl 1 2001 24 31
15. K. Podar, and K.C. Anderson The pathophysiological role of VEGF in hematological malignancies:therapeutic implications Blood 105 2005 1383 1395
16. A.E. Frankel, and P.S. Gill VEGF and myeloid leukemias Leuk Res 28 2004 675 677
17. B. Brunner, E. Gunsilius, P. Schumacher, H. Zwierzina, G. Gastl, and R. Stauder Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukaemia J Hematother Stem Cell Res 11 2002 119 125
18. A. Aguayo, H.M. Kantarjian, E.H. Estey, F.J. Giles, S. Verstovsek, and T. Manshouri Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes Cancer 95 2002 1923 1930
19. M. Mayerhofer, P. Valent, W.R. Sperr, J.D. Griffin, and C. Sillaber BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1α, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin Blood 100 2002 3767 3775
20. J. Janowska-Wieczorek, M. Majka, L. Marquez-Curtis, J.A. Wertheim, A.R. Turner, and M.Z. Ratajczak Bcr-abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants Leukemia 16 2002 1160 1166
21. R. He, B. Liu, C. Yang, R.C. Yang, G. Tobelem, and Z.C. Han Inhibition of K562 leukemia angiogenesis and growth by expression of antisense vascular endothelial growth factor (VEGF) sequence Cancer Gene Ther 10 2003 879 886
22. P. Murphy, N. Ahmed, and H.T. Hassan Increased serum levels of vascular endothelial growth factor correlate with splenomegaly in polycythemia vera Leuk Res 26 2002 1007 1010
23. J. Folkman Tumor angiogenesis: therapeutic implications N Engl J Med 285 1971 1182 1186
24. B. Joyce Cell adhesion and angiogenesis J Clin Invest 99 1997 373 376
25. A.E. Koch, M.M. Halloran, C.J. Haskell, M.R. Shah, and P.J. Ploverini Angiogensis mediated by soluble form of E-selectin and vascular cell adhesion molecule-1 Nature 376 1995 517 519
26. F. Bertolini, P. Manusco, A. Gobbi, and G. Pruneri The thin redline: angiogenesis in normal andmalignant hematopoiesis Exp Hematol 28 2000 993 1000
27. P. Korkolopoulou, N. Viniou, and N. Kavantzas Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study Leukemia 17 2003 78 97